Anti-CD154 antibody treatment induced modulation of the proliferating B population and the autoantibody response as well as a reduction of sCD154 levels, which seemed to protect monkeys from the clinical and pathologic effects of collagen-induced arthritis. The gene discussed is CD40LG; the disease is Arthritis.